Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

(Reuters) -Bristol Myers Squibb will spend $40 billion in the US over the next five years, CEO Christopher Boerner wrote in ...

Bristol Myers Squibb (BMS) plans to invest $40bn in the US over the next five years to bolster its research and manufacturing ...

In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...

The $40 billion investment will be spread across various R&D and manufacturing areas over the next five years.

A new executive order aims to smooth the path for getting U.S. manufacturing facilities up and running; HHS says it will ...

US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.

Bristol Myers Squibb Co. said it will spend $40 billion in the US over the next five years, joining a slew of drug companies ...

The announcement of new investment was first made by CEO Christopher Boerner in an opinion piece published in Stat News on ...

BMS CEO Christopher Boerner first revealed the plans in an opinion piece published in Stat News, in which he stated that the funds will be allocated for research and development (R&D), on ...

The announcement of new investment was first made by CEO Christopher Boerner in an opinion piece published in Stat News on Monday, and was later confirmed to Reuters by a company spokesperson.